MELK and neoplasm: Xenografts were established with MELK-overexpressing stable cells with or without elesclomol treatment, showing that elesclomol significantly reduced tumor volume and weight, which were increased by MELK overexpression (Fig. 7A–C and Supplementary Fig. 4C).